影响2型糖尿病患者新发非酒精性脂肪肝相关因素分析*

doi:10.3969/j.issn.1672-5069.2016.02.023

Abstract

Yan Jinsong, Yuan Dan, Li Dongsheng. Risk factors of non-alcoholic fatty liver in patients with diabetes type two[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 212-213.

[1] 范慧,张鹏睿,徐援,等.2型糖尿病合并非酒精性脂肪肝与胰岛素抵抗及心血管病变发生的关系研究.中国全科医学,2011,14（2）:147-150.
[2] 张喜婷,胡玲,王宁,等.2型糖尿病并发非酒精性脂肪肝的危险因素及其与糖尿病大血管病变的相关性研究.中国全科医学,2012,15（12）:1332-1334.
[3] 赵玲,杜娟,徐勉,等.2型糖尿病合并非酒精性脂肪性肝病与胰岛素抵抗及血脂代谢紊乱的关系.中华内分泌代谢杂志,2012,28（1）:16-20.
[4] 赵莹莹,郝久营,李凤敏,等.伴非酒精性脂肪肝的2型糖尿病患者的临床特点及与血清尿酸水平的关系.中国慢性病预防与控制,2011,19（1）:57-59.
[5] 赵新,陈延延,李晓通等.2型糖尿病合并非酒精性脂肪肝与糖尿病慢性并发症的相关性.中国慢性病预防与控制,2014,22（1）:26-28,32.
[6] 郑晓,赵伟,张晓会,等. 2型糖尿病患者非高密度脂蛋白胆固醇水平与非酒精性脂肪肝的相关性研究.实用医学杂志,2014,（3）:437-439.
[7] 李红,朱永芳,张曼云,等. 老年2型糖尿病合并非酒精性脂肪肝的相关因素分析. 实用医学杂志,2011,27（5）:821-823.
[8] 罗红.2型糖尿病与非糖尿病患者非酒精性脂肪肝发病情况的临床分析.临床军医杂志,2013,41（4）:345-346.
[9] Masuoka HC,Chalasani N. Nonalcoholic fatty liver disease:an emerging threat to obese and diabetic individuals. Ann New York Acad Sci,2013,42（1281）:106-122.
[10] Bacchi E,Negri C,Targher G,et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease （the RAED2 randomized trial）.Hepatology,2013,58（4）:1287-1295.
[11] 杨文,于晓红,王玉柱,等.糖尿病和糖代谢异常/糖耐量异常与非酒精性脂肪肝的相关研究.胃肠病学和肝病学杂志,2014,23（4）:438-440.
[12] 赵新,陈延延,李晓通,等.2型糖尿病合并非酒精性脂肪肝与糖尿病慢性并发症的相关性.中国慢性病预防与控制,2014,22（1）:26-28,32.
[13] 查月芳,刘芳,李力,等. 2型糖尿病合并非酒精性脂肪肝的临床特征及相关因素分析. 河北医药,2010,32（11）:1369-1371.
[14] 李朝喜,刘杨,史丽,等. T2DM并发非酒精性脂肪肝老年患者和动脉粥样硬化的关系及其相关影响因素研究.重庆医学,2015,44（17）:2414-2416.
[15] 徐亮,宓玉强,酒精性肝病治疗进展. 实用肝脏病杂志,2014,17（1）:89-91.

Risk factors of non-alcoholic fatty liver in patients with diabetes type two

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[3]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[4]	Qiu Jun, Wang Xueqing, Zhang Bo, et al. Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.
[5]	Zhang Wei, Shi Junmei, Wang Qian. Fisk factors for occurrence of hyperbilirubinemia in neonates [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 534-536.
[6]	Li Fang, Zou Guizhou, Ye Jun, et al. Clinical features and risk factors of patients with decompensated cirrhosis and sepsis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 557-560.
[7]	Du Min, Zhou Min, Ji Zongshu. Clinical features and risk factors of liver injuries in patients with sepsis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 369-372.
[8]	Liu Wenbo, Zhang Jianye, Bao Jiwu. Analysis of risk factors for stone recurrence in patients with common bile duct stones after ERCP and EST therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 437-440.
[9]	Wu Yaping, Zhou Bingqing, Jiang Peili. Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 196-199.
[10]	Cui Qinghua, Tao Hong, Wang Xiaoyue, et al.. Changes of serum glycosylated hemoglobin level and cardiac functions in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 69-72.
[11]	Wang Junyan, Chen Jianting, Zhang Ting, et al.. Risk factors of nosocomial infections in patients with hepatitis B liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 101-104.
[12]	Dong Xuelian, Zhang Wenjun.. Application of controlled attenuation parameter in screening individuals with risk of metabolic syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 868-871.
[13]	Zheng Zhenchuan, Xu Xihai.. Pathological and clinical features and factors affecting significant liver fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 713-716.
[14]	Yan Chenli, Wang Jingjing, Wang Jun.. Severity of coronary artery lesions and risk factors in patients with nonalcoholic fatty liver disease complicated by coronary heart disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 737-740.
[15]	Huang Jianwen, Yang Youchao, Xu Changqing. et al. Prognosis of patients with primary liver cancer after radical tumor resection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 521-524.